« Takeda, Lilly Win 99.6% Cut in Actos Punitive Damages | Main | Testosterone treatment: Fountain of youth or heart attack risk? »

October 31, 2014

Stronger warning on Iclusig blood clot risk

Quoted from http://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/stronger-warning-on-iclusig-blood-clot-risk/20066975.article

Stronger warning on Iclusig blood clot risk

The Pharmaceutical Journal, 30 OCT 2014

Warnings about the risks of developing a blood clot or blocked artery with Iclusig (ponatinib), a leukaemia treatment, are to be made more robust, following the results of a European Medicines Agency (EMA) review.

The EMA said that any risks would be likely to be linked to dosage but insufficient data meant that it did not have enough information to recommend that the existing starting dose of 45mg a day should change. The agency announced that it is launching a study into the safety and benefits of Iclusig, with a focus on dosage, to help clarify whether lowering the dose would also reduce the associated risks.

[Article continues at original source]

Posted at 03:19 PM in Iclusig |

Tags: blood clots risks, drug injury, EMA, European Medicines Agency, Iclusig, leukaemia treatment, ponatinib, warnings

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required